We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

139 hedge funds and large institutions have $1.18B invested in Nektar Therapeutics in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $1.62M

88.23% more ownership

Funds ownership: 0% → 88.23% (+88%)

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$12.7M
Puts
$1.62M
Net Calls
+$11.1M
Net Calls Change
+$11.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NKTR Hedge Fund Activity: Q2 2013 in Review

139 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2013, worth a combined $1.18B.

Buyers outnumbered sellers: 139 funds opened new NKTR positions and 0 closed out — a net gain of 139 holders — while 0 added to existing stakes and 0 trimmed.

  • 139 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.18B of Nektar Therapeutics stock for Q2 2013.
  • 139 funds opened new Nektar Therapeutics positions in Q2 2013 and 0 closed out, a net change of +139 holders.

Based on aggregated 13F filings for Q2 2013.